Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Name: Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
License: Public Domain

Nicox Ophthalmics, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

glaucoma hypertension

glaucoma, open-angle, hypertension, ocular

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 217120
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.